EUVIMEDOpdag EUVIMED
Randomisierte kontrollierte StudieOpen access

User Engagement and Feature Preferences in an AI-Powered mHealth Intervention for Diabetes Prevention: Secondary Analysis of a Randomized Controlled Trial

Benjamin Lalani iD, Gabriela Siew iD, Yllka Valdez iD, Aliyah Shehadeh iD, Daniel Zade iD, Kristin Riekert iD, Nestoras Mathioudakis iD, AI-DPP Study Group

JMIR mHealth and uHealth · 2026

DOI: 10.2196/92981 ↗

At a glance

Randomisierte kontrollierte Studie in JMIR mHealth and uHealth, 2026. Written by Benjamin Lalani and 7 co-authors. Institution: Harvard Medical School, Harvard University, Boston, MA, United States. Major MEDLINE topics: Patient Participation, Artificial Intelligence. 24 references. The full text is freely available in PubMed Central. Funded by: NIDDK NIH HHS, NCATS NIH HHS.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Prediabetes is highly prevalent and increasing globally, yet lifestyle interventions remain underused. AI-driven mobile health (mHealth) tools can help scale diabetes prevention efforts, but the key factors driving their success are not well understood.

Objective

This post hoc secondary analysis of a randomized controlled trial (RCT) aimed to characterize the most valued features and the role of user engagement in outcomes of a fully automated mHealth intervention for diabetes prevention.

Methods

Data from 151 participants with prediabetes and overweight or obesity who were assigned to an AI-based diabetes prevention program (Sweetch) in a parent RCT (NCT05056376) were analyzed. Engagement (defined as the total number of days the app was used) was categorized into tertiles (low, medium, and high). Baseline characteristics were compared across engagement groups using ANOVA, Kruskal-Wallis, and chi-square tests, and regression models assessed the association between engagement and achievement of diabetes risk reduction outcomes (≥5% weight loss, ≥4% weight loss with ≥150 min/week of physical activity, or ≥0.2 percentage point reduction in hemoglobin A1c [HbA1c] at 12 months). Perceived usefulness of intervention features was surveyed at 12 months.

Results

Median engagement was 98 (IQR 34-232) days. Older age (P

Subjects

MeSH terms (MEDLINE)

Patient ParticipationArtificial IntelligenceHumansFemaleMaleMiddle AgedTelemedicineAdultDigital HealthDiabetes Mellitus, Type 2Prediabetic StateAged

Author keywords

artificial intelligencediabetes preventiondigital healthlifestyle interventionmobile appobesityoverweightprediabetesreinforcement learninguser engagement

Authors and institutions

  • Harvard Medical School, Harvard University, Boston, MA, United States.
  • Division of Endocrinology, Diabetes & Metabolism, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
  • Division of Pulmonary and Critical Care Medicine, Department of Medicine, Johns Hopkins Medicine, Baltimore, MD, United States.
  • See Acknowledgments, .

ORCID profiles: Benjamin Lalani, Gabriela Siew, Yllka Valdez, Aliyah Shehadeh, Daniel Zade, Kristin Riekert, Nestoras Mathioudakis

Funding

  • NIDDK NIH HHS
  • NCATS NIH HHS

Cite

APA

Lalani, B., Siew, G., Valdez, Y., Shehadeh, A., Zade, D., Riekert, K., Mathioudakis, N., & AI-DPP Study Group (2026). User Engagement and Feature Preferences in an AI-Powered mHealth Intervention for Diabetes Prevention: Secondary Analysis of a Randomized Controlled Trial. JMIR mHealth and uHealth. https://doi.org/10.2196/92981

Vancouver

Lalani B, Siew G, Valdez Y, Shehadeh A, Zade D, Riekert K, et al. User Engagement and Feature Preferences in an AI-Powered mHealth Intervention for Diabetes Prevention: Secondary Analysis of a Randomized Controlled Trial. JMIR mHealth and uHealth. 2026. doi:10.2196/92981

BibTeX
@article{Lalani2026,
  author = {Lalani, Benjamin and Siew, Gabriela and Valdez, Yllka and Shehadeh, Aliyah and Zade, Daniel and Riekert, Kristin and Mathioudakis, Nestoras and AI-DPP Study Group, AI-DPP Study Group},
  title = {User Engagement and Feature Preferences in an AI-Powered mHealth Intervention for Diabetes Prevention: Secondary Analysis of a Randomized Controlled Trial},
  journal = {JMIR mHealth and uHealth},
  year = {2026},
  doi = {10.2196/92981}
}
Start for free →